Spiritus Mundi PLC
SPMU
Company Profile
Business description
Spiritus Mundi PLC is a special-purpose acquisition company incorporated in the United Kingdom. The company’s only segment is to Identify and acquire investment projects in the clinical diagnostics sector which includes Clinical laboratory services (clinical lab); Clinical Diagnostics (PCR and blood test); and Digital Health (Healthcare IT platform).
Contact
c/o Hill Dickinson LLP, 20 Primrose Street
8th Floor, The Broadgate Tower
LondonEC2A 2EW
GBRSector
Financial Services
Stock type
Cyclical
Industry
Shell Companies
Fiscal Year End
30 September 2025
Employees
Stocks News & Analysis
stocks
Is this ASX share a long-term buy?
Current operating conditions are challenging but over the long-term prospects are better.
stocks
Why Guzman and Reece's share reversals have a lot in common
Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.
stocks
Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?
Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,477.30 | 20.70 | -0.24% |
| CAC 40 | 8,143.92 | 92.85 | 1.15% |
| DAX 40 | 22,794.11 | 383.84 | 1.71% |
| Dow JONES (US) | 43,412.50 | 208.66 | -0.48% |
| FTSE 100 | 8,731.46 | 62.79 | 0.72% |
| HKSE | 23,787.93 | 753.91 | 3.27% |
| NASDAQ | 19,089.08 | 62.69 | 0.33% |
| Nikkei 225 | 38,142.37 | 95.42 | -0.25% |
| NZX 50 Index | 12,452.46 | 145.19 | 1.18% |
| S&P 500 | 5,957.19 | 1.94 | 0.03% |
| S&P/ASX 200 | 8,240.70 | 11.20 | -0.14% |
| SSE Composite Index | 3,380.21 | 34.17 | 1.02% |